StonvexLoading…
StonvexStonvexStonvexCore line items from CCRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $241.06M | $1.05B | $250.05M | $274.07M |
Operating Income | $-4.16M | $-84.41M | $-12.81M | $-6.84M |
Net Income | $-4.27M | $-94.85M | $-4.77M | $-6.66M |
EPS (Diluted) | $-0.14 | $-2.93 | $-0.15 | $-0.20 |
Total Assets | $451.07M | $448.95M | $538.23M | $553.82M |
Total Liabilities | $138.27M | $126.13M | $130.09M | $141.58M |
Cash & Equivalents | $105.58M | $108.74M | $99.13M | $81.19M |
Free Cash Flow OCF − CapEx | $3.31M | $40.09M | $23.97M | $6.04M |
Shares Outstanding | 31.24M | 31.72M | 32.52M | 32.52M |